OTCPK:ZMSP.F

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

Zecotek Photonics Inc., a photonics technology company, develops various photonics technologies and products for commercial and research applications in medical, bio-science, high-energy physics, pharmaceutical research, material processing, engineering and industrial design, and multi-media markets in Canada. More Details


Snowflake Analysis

Weak fundamentals or lack of information.

Share Price & News

How has Zecotek Photonics's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: ZMSP.F's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

0%

ZMSP.F

0.6%

US Medical Equipment

0.09%

US Market


1 Year Return

-65.0%

ZMSP.F

14.8%

US Medical Equipment

12.6%

US Market

Return vs Industry: ZMSP.F underperformed the US Medical Equipment industry which returned 14.8% over the past year.

Return vs Market: ZMSP.F underperformed the US Market which returned 12.6% over the past year.


Shareholder returns

ZMSP.FIndustryMarket
7 Day0%0.6%0.09%
30 Day-35.8%0.9%-1.6%
90 Day-53.3%11.4%7.9%
1 Year-65.0%-65.0%15.8%14.8%15.2%12.6%
3 Year-96.6%-96.6%72.3%67.9%38.9%29.6%
5 Year-97.8%-97.8%148.2%129.3%87.6%66.5%

Price Volatility Vs. Market

How volatile is Zecotek Photonics's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Zecotek Photonics undervalued compared to its fair value and its price relative to the market?


In this section, we usually try to help investors determine whether Zecotek Photonics is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Zecotek Photonics has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

  • Take a look at our analysis of ZMSP.F's management and see if the CEO's compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don't know where to start, we recommend reading through Zecotek Photonics regulatory filings here.
  • Explore potentially undervalued companies in the Healthcare industry.

Future Growth

How is Zecotek Photonics forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

26.1%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Zecotek Photonics has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

  • Take a look at our analysis of ZMSP.F’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on theOTC Markets Website. If you are looking for more of a qualitative research into the company, you can access Zecotek Photonics's filings and announcementshere.
  • Explore growth companies in the Healthcare industry.

Past Performance

How has Zecotek Photonics performed over the past 5 years?

13.0%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: ZMSP.F is currently unprofitable.

Growing Profit Margin: ZMSP.F is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: ZMSP.F is unprofitable, but has reduced losses over the past 5 years at a rate of 13% per year.

Accelerating Growth: Unable to compare ZMSP.F's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ZMSP.F is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-0.2%).


Return on Equity

High ROE: ZMSP.F's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Next Steps

Financial Health

How is Zecotek Photonics's financial position?


Financial Position Analysis

Short Term Liabilities: ZMSP.F has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: ZMSP.F has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: ZMSP.F has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: ZMSP.F's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: ZMSP.F has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: ZMSP.F has less than a year of cash runway if free cash flow continues to reduce at historical rates of 4% each year


Next Steps

Dividend

What is Zecotek Photonics's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate ZMSP.F's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate ZMSP.F's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if ZMSP.F's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if ZMSP.F's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of ZMSP.F's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

  • Explore strong dividend paying companies in the Healthcare industry.

Management

How experienced are the management team and are they aligned to shareholders interests?

11.4yrs

Average management tenure


CEO

A. Zerrouk

15.67yrs

Tenure

CA$769,399

Compensation

Dr. A. Faouzi Zerrouk is the Founder of Zecotek Photonics Inc and has been its Chairman, President and Chief Executive Officer since December 31, 2004. Dr. Zerrouk Principal Founder of Zecotek Holdings Ltd ...


CEO Compensation Analysis

Compensation vs Market: A.'s total compensation ($USD583.03K) is about average for companies of similar size in the US market ($USD589.17K).

Compensation vs Earnings: A.'s compensation has increased whilst the company is unprofitable.


Leadership Team

NamePositionTenureCompensationOwnership
A. Zerrouk
Founder15.67yrsCA$769.40k7.99%
CA$ 99.9k
Jiang Chen
Chief Financial Officer1.83yrsCA$69.00kno data
Serge Khorev
Senior Vice President of Technology9.25yrsno datano data
Zair Sadygov
Chief Scientist of Medical Imaging Division13.5yrsno datano data
Shirley Kancs
Assistant Secretaryno dataCA$21.67kno data

11.4yrs

Average Tenure

Experienced Management: ZMSP.F's management team is seasoned and experienced (11.4 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
A. Zerrouk
Founder15.67yrsCA$769.40k7.99%
CA$ 99.9k
Erich Sager
Independent Director15.67yrsCA$24.00k0.38%
CA$ 4.7k
Thomas Lewellen
Member of Scientific Advisory Boardno datano datano data
Tiong-Ann Teoh
Member of Scientific Advisory Board12.83yrsno datano data
Sergei Tsakunov
Independent Director1.83yrsno datano data

14.3yrs

Average Tenure

Experienced Board: ZMSP.F's board of directors are seasoned and experienced ( 14.3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Zecotek Photonics Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Zecotek Photonics Inc.
  • Ticker: ZMSP.F
  • Exchange: OTCPK
  • Founded: 1983
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: CA$1.649m
  • Listing Market Cap: CA$1.250m
  • Shares outstanding: 164.93m
  • Website: https://www.zecotek.com

Location

  • Zecotek Photonics Inc.
  • 6900 Graybar Road
  • Unit 2325
  • Richmond
  • British Columbia
  • V6W 0A5
  • Canada

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
W1IDB (Deutsche Boerse AG)YesCommon SharesDEEURSep 1988
ZMSP.FOTCPK (Pink Sheets LLC)YesCommon SharesUSUSDSep 1988
ZMSTSXV (TSX Venture Exchange)YesCommon SharesCACADSep 1988

Biography

Zecotek Photonics Inc., a photonics technology company, develops various photonics technologies and products for commercial and research applications in medical, bio-science, high-energy physics, pharmaceu ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/09/20 07:07
End of Day Share Price2020/09/18 00:00
Earnings2020/04/30
Annual Earnings2019/07/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.